DK251478A - Fremgangsmaade til fremstilling af pencillansyre-1,1-dioxider - Google Patents

Fremgangsmaade til fremstilling af pencillansyre-1,1-dioxider

Info

Publication number
DK251478A
DK251478A DK251478A DK251478A DK251478A DK 251478 A DK251478 A DK 251478A DK 251478 A DK251478 A DK 251478A DK 251478 A DK251478 A DK 251478A DK 251478 A DK251478 A DK 251478A
Authority
DK
Denmark
Prior art keywords
dioxides
procedure
preparation
pencillanic acid
pencillanic
Prior art date
Application number
DK251478A
Other languages
English (en)
Other versions
DK155740C (da
DK155740B (da
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK251478(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of DK251478A publication Critical patent/DK251478A/da
Priority to DK428682A priority Critical patent/DK156480C/da
Publication of DK155740B publication Critical patent/DK155740B/da
Application granted granted Critical
Publication of DK155740C publication Critical patent/DK155740C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK251478A 1977-06-07 1978-06-06 Analogifremgangsmaade til fremstilling af penicillansyre-1,1-dioxid, visse estere og fysiologisk acceptable salte heraf DK155740C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK428682A DK156480C (da) 1977-06-07 1982-09-27 Penicillansyre-1-oxider til anvendelse som mellemprodukter ved fremstilling af terapeutisk aktive penicillansyre-1,1-dioxidderivater

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US80432077 1977-06-07
US87938178A 1978-02-21 1978-02-21
US87938178 1978-02-21

Publications (3)

Publication Number Publication Date
DK251478A true DK251478A (da) 1978-12-08
DK155740B DK155740B (da) 1989-05-08
DK155740C DK155740C (da) 1989-10-23

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
DK251478A DK155740C (da) 1977-06-07 1978-06-06 Analogifremgangsmaade til fremstilling af penicillansyre-1,1-dioxid, visse estere og fysiologisk acceptable salte heraf

Country Status (35)

Country Link
AR (1) AR224111A1 (da)
AT (2) AT360649B (da)
AU (1) AU513636B2 (da)
BE (1) BE867859A (da)
BG (2) BG34614A3 (da)
CH (1) CH634073A5 (da)
CS (1) CS208472B2 (da)
DD (2) DD140888A5 (da)
DE (2) DE2824535C3 (da)
DK (1) DK155740C (da)
EG (1) EG13869A (da)
FI (1) FI66003C (da)
FR (2) FR2393804A1 (da)
GB (1) GB2000138B (da)
GR (1) GR72255B (da)
HK (1) HK13184A (da)
HU (1) HU180042B (da)
IE (1) IE47079B1 (da)
IL (2) IL54867A (da)
IN (1) IN149747B (da)
IT (1) IT1096381B (da)
KE (1) KE3355A (da)
LU (1) LU79774A1 (da)
MY (1) MY8500092A (da)
NL (2) NL180009C (da)
NO (2) NO151746C (da)
NZ (1) NZ187476A (da)
OA (1) OA05964A (da)
PH (3) PH26810A (da)
PL (1) PL114501B1 (da)
PT (1) PT68146A (da)
SE (2) SE436206B (da)
SG (1) SG65383G (da)
SU (1) SU860706A1 (da)
YU (1) YU41829B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (da) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (da) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (da) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DD140888A5 (de) 1980-04-02
IL54867A (en) 1981-11-30
IL54867A0 (en) 1978-08-31
GB2000138B (en) 1982-03-03
AT360649B (de) 1981-01-26
SE7806628L (sv) 1978-12-08
LU79774A1 (fr) 1980-01-22
PH26810A (en) 1992-11-05
NL930064I1 (nl) 1993-09-01
GB2000138A (en) 1979-01-04
PL207396A1 (pl) 1979-06-04
DK155740C (da) 1989-10-23
SU860706A1 (ru) 1981-08-30
NO823126L (no) 1978-12-08
IL62168A0 (en) 1981-03-31
IT1096381B (it) 1985-08-26
SE8305916L (sv) 1983-10-27
PT68146A (en) 1978-07-01
BE867859A (fr) 1978-12-06
PH21116A (en) 1987-07-16
ATA411278A (de) 1980-06-15
FI781800A (fi) 1978-12-08
NO151746C (no) 1985-06-05
SG65383G (en) 1985-03-29
DE2824535A1 (de) 1978-12-14
IN149747B (da) 1982-04-03
CS208472B2 (en) 1981-09-15
ATA128580A (de) 1981-02-15
NL180009C (nl) 1986-12-16
NO151746B (no) 1985-02-18
DE2824535C3 (de) 1981-01-22
PL114501B1 (en) 1981-02-28
YU41829B (en) 1988-02-29
DE2857263B2 (de) 1981-04-23
FR2393805A1 (fr) 1979-01-05
FR2393804A1 (fr) 1979-01-05
BG34614A3 (en) 1983-10-15
NL930064I2 (nl) 1994-04-18
DE2857263C3 (de) 1981-12-17
AU513636B2 (en) 1980-12-11
BG34615A3 (en) 1983-10-15
DK155740B (da) 1989-05-08
CH634073A5 (en) 1983-01-14
NZ187476A (en) 1982-08-17
PH16465A (en) 1983-10-20
NO781970L (no) 1978-12-08
FR2393804B1 (da) 1980-11-07
SE436206B (sv) 1984-11-19
SE447995B (sv) 1987-01-12
YU117078A (en) 1983-01-21
FR2393805B1 (da) 1984-02-24
NO152448B (no) 1985-06-24
EG13869A (en) 1983-03-31
IE781140L (en) 1978-12-07
NL7806126A (nl) 1978-12-11
KE3355A (en) 1983-12-16
NO152448C (no) 1985-10-02
DD148585A5 (de) 1981-06-03
SE8305916D0 (sv) 1983-10-27
FI66003C (fi) 1984-08-10
AT364084B (de) 1981-09-25
HK13184A (en) 1984-02-24
FI66003B (fi) 1984-04-30
IE47079B1 (en) 1983-12-14
MY8500092A (en) 1985-12-31
AR224111A1 (es) 1981-10-30
OA05964A (fr) 1981-06-30
HU180042B (en) 1983-01-28
GR72255B (da) 1983-10-06
IT7824270A0 (it) 1978-06-06
AU3683878A (en) 1979-12-06
DE2824535B2 (de) 1980-05-14

Similar Documents

Publication Publication Date Title
DK251478A (da) Fremgangsmaade til fremstilling af pencillansyre-1,1-dioxider
DK562078A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxider
DK13878A (da) Fremgangsmaade til fremstilling af 11beta-substituerede 4,9-diensteroider
DK110778A (da) Fremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer
DK306978A (da) Fremgangsmaade til fremstilling af 1-acyl-2-cyanaziridiner
DK569678A (da) Fremgangsmaade til fremstilling af 2alfa-cyano-3-oxosteroider
DK484677A (da) Fremgangsmaade til fremstilling af furokumariner
DK145701C (da) Fremgangsmaade til fremstilling af ergotalkaloider
DK466878A (da) Fremgangsmaade til fremstilling af 0-methallyloxyphenol
DK465578A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner
DK483378A (da) Fremgangsmaade til fremstilling af 2,4-difluoranilin
DK237978A (da) Fremgangsmaade til fremstilling af alfafluormethyl-alfa-aminoalkansyrer
DK154949C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK436978A (da) Fremgangsmaade til fremstilling af sarcosinoxidase
DK67978A (da) Fremgangsmaade til fremstilling af 1,3,5-triazin2,6-dioner
DK577078A (da) Fremgangsmaade til fremstilling af trans-4a-aryloctahydro-1h-2-pyridiner
DK548478A (da) Fremgangsmaade til fremstilling af 2,4,5-trichlorphenol
DK5778A (da) Femgangsmaade til fremstilling af 4-diphenylmethylen-1-hydroxybenzyl-piperidiner
DK364578A (da) Fremgangsmaade til fremstilling af hydroxyphenylhydantoin
DK248978A (da) Fremgangsmaade til fremstilling af hydroxy-alfa-aminobenzylpenicillin
DK500178A (da) Fremgangsmaade til fremstilling af 2,4-diamino-5-benzylpuromidiner
DK339777A (da) Fremgangsmaade til fremstilling af 2-benzylperhydroazepiner
DK383978A (da) Fremgangsmaade til fremstilling af 2-chlorsulfinylazetidin-4-oner
DK75778A (da) Fremgangsmaade til fremstilling af 17alfaacetylenderivater af androst-4-en.
DK158976C (da) Fremgangsmaade til fremstilling af alfa-cyanobenzyl

Legal Events

Date Code Title Description
PUP Patent expired